Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.01200.0000 (0.00%)
At close: 04:21PM SGT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-2,488
-2,488
-9,374
-5,984
-4,651
Depreciation & amortisation
241
241
1,183
1,252
996.335
Stock-based compensation
0
0
-67
106
1,368
Change in working capital
-10
-10
177
-390
-871.331
Inventory
-139
-139
115
-394
-785.148
Other working capital
-1,966
-1,966
-3,157
-5,202
-2,881
Other non-cash items
80
80
138
146
707.012
Net cash provided by operating activities
-1,966
-1,966
-3,064
-4,641
-2,431
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-93
-561
-449.448
Acquisitions, net
-
-
-
0
-89.979
Other investing activities
-2,689
-2,689
98
-300
-
Net cash used for investing activities
-2,689
-2,689
5
-860
-539.427
Net change in cash
-4,855
-4,855
1,123
-6,647
4,527
Cash at beginning of period
5,029
5,029
3,960
10,669
6,030
Cash at end of period
183
183
5,029
3,960
10,669
Free cash flow
Operating cash flow
-1,966
-1,966
-3,064
-4,641
-2,431
Capital expenditure
-
-
-93
-561
-449.448
Free cash flow
-1,966
-1,966
-3,157
-5,202
-2,881